Related Experiment Video
Updated: May 8, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II)
Chunwei Cheng1, Yan Liu, Hao Song
1Key Laboratory of Drug Targeting and Drug Delivery Systems of the Ministry of Education, Department of Medicinal Natural Products, West China School of Pharmacy, Sichuan University, Chengdu 610041, China. chengchunwei666@163.com
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) continues to be a major problem, causing severe and intractable infections worldwide. MRSA is resistant to all beta-lactam antibiotics, and alternative treatments are limited. A very limited number of new antibiotics have been discovered over the last half-century, novel agents for the treatment of MRSA infections are urgently needed. Marinopyrrole A was reported to show antibiotic activity against MRSA in 2008. After we reported the first total synthesis of (±)-marinopyrrole A, we designed and synthesized a series of marinopyrrole derivatives. Our structure activity relationship (SAR) studies of these novel derivatives against a panel of Gram-positive pathogens in antibacterial assays have revealed that a para-trifluoromethyl analog (33) of marinopyrrole A is ≥ 63-, 8-, and 4-fold more potent than vancomycin against methicillin-resistant Staphylococcus epidermidis (MRSE), methicillin-susceptible Staphylococcus aureus (MSSA) and MRSA, respectively. The results provide valuable information in the search for new-generation antibiotics.
Insights
Novel marinopyrrole derivatives show potent activity against antibiotic-resistant bacteria. A specific analog demonstrates significantly enhanced efficacy compared to vancomycin, offering hope for new MRSA infection treatments.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Drug Discovery
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat due to widespread antibiotic resistance.
- Existing treatment options for MRSA infections are limited, with a scarcity of newly discovered antibiotics in recent decades.
- Marinopyrrole A, identified in 2008, exhibited initial antibiotic activity against MRSA.
Purpose of the Study:
- To design and synthesize novel marinopyrrole derivatives.
- To investigate the structure-activity relationships (SAR) of these derivatives against Gram-positive pathogens.
- To identify potent analogs for the development of new antibiotics against resistant bacteria.
Main Methods:
- Total synthesis of marinopyrrole derivatives based on Marinopyrrole A.
- Structure-activity relationship (SAR) studies.
- Antibacterial assays against a panel of Gram-positive pathogens, including MRSA, MRSE, and MSSA.
Main Results:
- A series of novel marinopyrrole derivatives were synthesized.
- Structure-activity relationship studies identified key modifications for enhanced potency.
- A para-trifluoromethyl analog (33) demonstrated superior activity, being 63-fold more potent against MRSE, 8-fold against MSSA, and 4-fold against MRSA compared to vancomycin.
Conclusions:
- The synthesized marinopyrrole derivatives represent promising candidates for novel antibiotic development.
- The para-trifluoromethyl analog exhibits significant potential for treating infections caused by resistant Gram-positive bacteria.
- These findings contribute valuable insights for the ongoing search for next-generation antibiotics.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Gene Regulation in Microbial Communities: Quorum Sensing
